Efficacy of low-dose Aracytine in 3 cases of refractory anemia in transformation in children.
A treatment with cytosine arabinoside in low doses is administered to 3 children affected by refractory anemia with myeloblast in transformation. The remission is obtained in 3 cases. One child relapsed at 24 months. The other 2 children are in persistent remission at 40 and 48 months. This relatively non-aggressive mode of treatment seems to have a place in children affected by myelodysplasia and for whom allografting from an HLA-identical donor is not available.